Amneal is not ruling out strategic acquisitions outside of the US, but any deal would have to deliver considerable commercial scale • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
